Shanghai, China

Quanrong Shen

This inventor holds 1 USPTO granted patent. Top assignee: Servier Pharmaceuticals LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quanrong Shen. Retrieved from https://idiyas.com/inventor/quanrong-shen-43unj7ec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Quanrong Shen: Patent Inventor in Shanghai

Introduction

Quanrong Shen is an inventor associated with Shanghai, China, and Servier Pharmaceuticals LLC. His patent work concerns pharmaceutical compounds and their potential uses.

Latest Patents

The supplied information lists one patent for Shen: “Carbonyl Substituted Diazaspiro Compounds and Its Use.” The patent describes compounds of Formula I, with variables defined in the specification, as well as pharmaceutical compositions containing them, methods for preparing them, and their use. Shen is credited with 1 patent in the information provided.

Career Highlights

Shen’s listed invention focuses on diazaspiro compounds and their pharmaceutical applications. His association with Servier Pharmaceuticals LLC connects his patent work with a company active in the pharmaceutical field.

Collaborations

The supplied information names Taishan Hu and Bryan Huang as Shen’s coworkers. Their names are provided as collaborators in his professional context, though specific roles in the patent are not stated.

Conclusion

Quanrong Shen’s listed patent reflects work on pharmaceutical compounds, their preparation, and their potential use, alongside his association with Servier Pharmaceuticals LLC.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…